Noriko Isayama
Noriko Isayama has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Erika Maeda
Department of Cardiology, Uenonomori Animal Hospital, Tokyo, Japan
4 shared publications- Kenta Sasaki
Uenonomori Animal Hospital, Yanaka 1-5-11 B1F, Taito, Tokyo 110-0001, Japan
4 shared publications - Takeshi Mizuno
Tokyo Animal Cardiothoracic Surgery (TACTS), Yanaka 1-5-11 B1F, Taito, Tokyo 110-0001, Japan; Veterinary Medical Center, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
4 shared publications Yusuke Uchimura
Department of Cardiology, Uenonomori Animal Hospital, Tokyo, Japan
4 shared publications- Erika Maeda
Uenonomori Animal Hospital, Yanaka 1-5-11 B1F, Taito, Tokyo 110-0001, Japan
3 shared publications Kenta Sasaki
Department of Cardiology, Uenonomori Animal Hospital, Tokyo, Japan
3 shared publications
Latest Publications
- Open Access
Complete Mitral Valve Reconstruction Using Fresh Autologous Pericardium in a Chihuahua with Infective Endocarditis: A Case Report
In humans, surgical repair is commonly performed for infective endocarditis (IE) associated with mitral valve destruction. However, extensive valve destruction may make repair impossible and require prosthetic valve replacement. In small-breed dogs, appropriately sized prosthetic valves are lacking, and complete surgical mitral valve reconstruction in dogs has not been reported. We encountered a Chihuahua that developed IE after mitral valve repair. During reoperation for progressive mitral regurgitation recurrence, the mitral leaflets were extensively destroyed and torn, and re-repair using native tissue was impossible; the entire valve was therefore reconstructed with fresh autologous pericardium. A graft was harvested and fashioned into a cylindrical valve based on a design previously described in a human study. Intraoperative saline testing and immediate postoperative echocardiography confirmed adequate opening and closure of the reconstructed pericardial valve, with only mild mitral regurgitation and no stenosis. The dog died on the second day after reoperative day of an uncontrolled infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. This case demonstrates that an autologous pericardial valve can provide short-term mechanical function as a mitral valve in a small-breed dog and indicates that infection control is the principal determinant of outcome.
Open AccessComplete Mitral Valve Reconstruction Using Fresh Autologous Pericardium in a Chihuahua with Infective Endocarditis: A Case Report
In humans, surgical repair is commonly performed for infective endocarditis (IE) associated with mitral valve destruction. However, extensive valve destruction may make repair impossible and require prosthetic valve replacement. In small-breed dogs, appropriately sized prosthetic valves are lacking, and complete surgical mitral valve reconstruction in dogs has not been reported. We encountered a Chihuahua that developed IE after mitral valve repair. During reoperation for progressive mitral regurgitation recurrence, the mitral leaflets were extensively destroyed and torn, and re-repair using native tissue was impossible; the entire valve was therefore reconstructed with fresh autologous pericardium. A graft was harvested and fashioned into a cylindrical valve based on a design previously described in a human study. Intraoperative saline testing and immediate postoperative echocardiography confirmed adequate opening and closure of the reconstructed pericardial valve, with only mild mitral regurgitation and no stenosis. The dog died on the second day after reoperative day of an uncontrolled infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. This case demonstrates that an autologous pericardial valve can provide short-term mechanical function as a mitral valve in a small-breed dog and indicates that infection control is the principal determinant of outcome.
- Open Access
- 23 February 2026
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 65, 63-69
Fresh autologous pericardial patch for surgical repair of mitral valve leaflet degeneration in a dog
- 23 February 2026
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 65, 63-69
Open AccessFresh autologous pericardial patch for surgical repair of mitral valve leaflet degeneration in a dog
- Open Access
Extracorporeal Membrane Oxygenation for Acute Respiratory Failure in a Dog
A 3-year-old West Highland White Terrier presented to our hospital with dyspnea following aspiration of barium contrast medium during diagnostic imaging for a suspected esophageal foreign body (day 0). Barium contrast radiography had revealed a foreign body in the lower esophagus. During anesthesia, the patient regurgitated and developed respiratory failure and cyanosis. Despite immediate intubation, suction, and ventilatory management, respiratory parameters remained poor. Respiratory support with extracorporeal membrane oxygenation (ECMO) enabled control of blood gas parameters, and tracheobronchial lavage with temporary complete airway occlusion was performed. ECMO was withdrawn once the respiratory status normalized (total support time: 3 h). Considering the possibility of hypoxia-induced brain damage, the patient was extubated on day 1. The dog was alert, changed positions, and drank water independently 5 h after extubation. However, neurological symptoms were observed 1 h later. Cranial magnetic resonance imaging was performed on day 6 owing to persistent neurological symptoms. Although no ECMO-related complications, such as cerebral infarction, hemorrhage, or herniation, were observed, the white matter exhibited hyposignal, indicating hypoxic encephalopathy. The patient died on day 8, without improvement in neurological symptoms. ECMO is an effective treatment option for dogs with respiratory failure, and its prompt introduction may improve survival.
Open AccessExtracorporeal Membrane Oxygenation for Acute Respiratory Failure in a Dog
A 3-year-old West Highland White Terrier presented to our hospital with dyspnea following aspiration of barium contrast medium during diagnostic imaging for a suspected esophageal foreign body (day 0). Barium contrast radiography had revealed a foreign body in the lower esophagus. During anesthesia, the patient regurgitated and developed respiratory failure and cyanosis. Despite immediate intubation, suction, and ventilatory management, respiratory parameters remained poor. Respiratory support with extracorporeal membrane oxygenation (ECMO) enabled control of blood gas parameters, and tracheobronchial lavage with temporary complete airway occlusion was performed. ECMO was withdrawn once the respiratory status normalized (total support time: 3 h). Considering the possibility of hypoxia-induced brain damage, the patient was extubated on day 1. The dog was alert, changed positions, and drank water independently 5 h after extubation. However, neurological symptoms were observed 1 h later. Cranial magnetic resonance imaging was performed on day 6 owing to persistent neurological symptoms. Although no ECMO-related complications, such as cerebral infarction, hemorrhage, or herniation, were observed, the white matter exhibited hyposignal, indicating hypoxic encephalopathy. The patient died on day 8, without improvement in neurological symptoms. ECMO is an effective treatment option for dogs with respiratory failure, and its prompt introduction may improve survival.
- Open Access
- 9 October 2025
- Published by MDPI AG in Preprints.org
Extracorporeal Membrane Oxygenation for Acute Respiratory Failure in a Dog
A 3-year-old West Highland White Terrier was presented to our hospital with dyspnoea following aspiration of barium contrast medium during diagnostic imaging for a suspected oesophageal foreign body (day 0). Barium contrast radiography had revealed a foreign body in the lower oesophagus. During anaesthesia, the patient regurgitated and developed respiratory failure and cyanosis. Despite immediate intubation, suction, and ventilatory management, the respiratory parameters remained poor. Respiratory support with extracorporeal membrane oxygenation (ECMO) allowed to control blood gas parameters, and tracheobronchial lavage with temporary complete airway occlusion was performed. ECMO was withdrawn once the respiratory status normalised. The total support time was 3 h. Considering the possibility of hypoxia-induced brain damage, the patient was extubated on day 1. The dog was alert, changed positions, and drank water independently 5 h after extubation. However, neurological symptoms were observed 1 h later. Cranial magnetic resonance imaging was performed on day 6 because of persistent neurological symptoms. Although no ECMO-related complications, such as cerebral infarction, haemorrhage, or herniation, were observed, the white matter showed hyposignal, indicating hypoxic encephalopathy. The patient died on day 8, without improvement in neurological symptoms. ECMO is an effective treatment option for dogs with respiratory failure, and its prompt introduction could improve survival in applicable cases.
- 9 October 2025
- Published by MDPI AG in Preprints.org
Open AccessExtracorporeal Membrane Oxygenation for Acute Respiratory Failure in a Dog
A 3-year-old West Highland White Terrier was presented to our hospital with dyspnoea following aspiration of barium contrast medium during diagnostic imaging for a suspected oesophageal foreign body (day 0). Barium contrast radiography had revealed a foreign body in the lower oesophagus. During anaesthesia, the patient regurgitated and developed respiratory failure and cyanosis. Despite immediate intubation, suction, and ventilatory management, the respiratory parameters remained poor. Respiratory support with extracorporeal membrane oxygenation (ECMO) allowed to control blood gas parameters, and tracheobronchial lavage with temporary complete airway occlusion was performed. ECMO was withdrawn once the respiratory status normalised. The total support time was 3 h. Considering the possibility of hypoxia-induced brain damage, the patient was extubated on day 1. The dog was alert, changed positions, and drank water independently 5 h after extubation. However, neurological symptoms were observed 1 h later. Cranial magnetic resonance imaging was performed on day 6 because of persistent neurological symptoms. Although no ECMO-related complications, such as cerebral infarction, haemorrhage, or herniation, were observed, the white matter showed hyposignal, indicating hypoxic encephalopathy. The patient died on day 8, without improvement in neurological symptoms. ECMO is an effective treatment option for dogs with respiratory failure, and its prompt introduction could improve survival in applicable cases.
- Open Access
- 18 December 2024
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 11, 1444742
Surgical technique for mitral valve repair in dogs using a novel method to anchor artificial chordae tendineae with emphasis on key intraoperative decision points
Objectives: Surgical options for mitral valve repair in dogs are unstandardized and influenced by various factors. This study describes a four-point surgical technique (MI-4) to reduce mitral regurgitation and provides data from a study of dogs with 12 months of follow up.Methods: Twenty-five dogs with stages C or D mitral insufficiency were treated by one of two surgeons using the MI-4 procedure at Ueno no Mori Animal Hospital between October 2021 and May 2023. The surgical technique comprised: (I) determination of the valve annulus dimensions by measuring between the trigones, (II) triad-anchored chordae tendinea reconstruction, (III) determination of the appropriate position and number of chordae tendineae on the leaflets, and (IV) appropriate height determination. The regurgitation percentage was measured using B-mode color Doppler flow in the atrium in the four-chamber left long-axis view.Results: There were no intraoperative complications, and 23, 23, and 18 dogs were successfully re-evaluated at 1, 6, and 12 months, respectively (5 dogs have not yet reached the 12-month follow-up point). The regurgitation percentage decreased from 73.0% (interquartile range, 58.1–81.5%) preoperatively to 2.1% (0.0–8.8%), 4.6% (0.1–10.8), and 1.3% (0.0–7.1) at 1, 6, and 12 months postoperatively, respectively. All surviving dogs improved clinically.Conclusion: The MI-4 surgical technique was performed in dogs with mitral valve insufficiency with no significant complications. The surgery reduced the regurgitation percentage postoperatively, with benefits seen at least 12 months after surgery.
- 18 December 2024
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 11, 1444742
Open AccessSurgical technique for mitral valve repair in dogs using a novel method to anchor artificial chordae tendineae with emphasis on key intraoperative decision points
Objectives: Surgical options for mitral valve repair in dogs are unstandardized and influenced by various factors. This study describes a four-point surgical technique (MI-4) to reduce mitral regurgitation and provides data from a study of dogs with 12 months of follow up.Methods: Twenty-five dogs with stages C or D mitral insufficiency were treated by one of two surgeons using the MI-4 procedure at Ueno no Mori Animal Hospital between October 2021 and May 2023. The surgical technique comprised: (I) determination of the valve annulus dimensions by measuring between the trigones, (II) triad-anchored chordae tendinea reconstruction, (III) determination of the appropriate position and number of chordae tendineae on the leaflets, and (IV) appropriate height determination. The regurgitation percentage was measured using B-mode color Doppler flow in the atrium in the four-chamber left long-axis view.Results: There were no intraoperative complications, and 23, 23, and 18 dogs were successfully re-evaluated at 1, 6, and 12 months, respectively (5 dogs have not yet reached the 12-month follow-up point). The regurgitation percentage decreased from 73.0% (interquartile range, 58.1–81.5%) preoperatively to 2.1% (0.0–8.8%), 4.6% (0.1–10.8), and 1.3% (0.0–7.1) at 1, 6, and 12 months postoperatively, respectively. All surviving dogs improved clinically.Conclusion: The MI-4 surgical technique was performed in dogs with mitral valve insufficiency with no significant complications. The surgery reduced the regurgitation percentage postoperatively, with benefits seen at least 12 months after surgery.
- Open Access
- 21 November 2022
- Published by Wiley in Veterinary Medicine and Science
- Vol. 9 (1) , 68-75
Utility and safety of nafamostat mesilate for anticoagulation in dogs
Background: Surgical interventions are recommended for cases of advanced mitral regurgitation, however, limited facilities are available. The most prominent complication in such procedures is heparin-derived bleeding. An alternative anticoagulant to heparin, nafamostat mesilate (NM), can reduce the occurrence of complications associated with heparin such as bleeding or shock. Objectives: This study aimed to evaluate the utility and safety of using NM during anaesthesia in canines. Methods: Six healthy adult Beagle dogs were anaesthetised, and NM was administered intravenously as a 10 mg/kg bolus dose over 5 min, followed by a continuous infusion of 10 mg/kg/h over 20 min. Blood tests and blood pressure measurements were performed at 0, 5, 25 and 55 min after NM administration. Results: Activated thromboplastin times at 0, 25 and 55 min were 13.0 +/- 0.7 s, 106.7 +/- 13.3 s and 28.2 +/- 2.9 s, respectively, with a significant difference between 0 and 25 min (p <0.01) only. No significant differences were observed in prothrom bin time, antithrombin, fibrinogen and fibrin degradation product concentrations between timepoints. Activated clotting times (ACTs) at 0, 5, 25 and 55 min were 119.5 +/- 9.6 s, 826.7 +/- 78.6 s, 924.8 +/- 42.4 s and 165.2 +/- 13.5 s, respectively. Significant differences were observed between 0 and 5 min (p < 0.05) and between 0 and 25 min (p < 0.05). Blood pressure changes occurred in four dogs (66.7%). No other serious adverse effects were observed. Conclusions: ACT results indicated that NM use in anaesthetised healthy dogs was sufficient to obtain procedural anticoagulation with minimal adverse effects. However, these preliminary data require validation in further studies on cardiopulmonary bypass surgery.
- 21 November 2022
- Published by Wiley in Veterinary Medicine and Science
- Vol. 9 (1) , 68-75
Open AccessUtility and safety of nafamostat mesilate for anticoagulation in dogs
Background: Surgical interventions are recommended for cases of advanced mitral regurgitation, however, limited facilities are available. The most prominent complication in such procedures is heparin-derived bleeding. An alternative anticoagulant to heparin, nafamostat mesilate (NM), can reduce the occurrence of complications associated with heparin such as bleeding or shock. Objectives: This study aimed to evaluate the utility and safety of using NM during anaesthesia in canines. Methods: Six healthy adult Beagle dogs were anaesthetised, and NM was administered intravenously as a 10 mg/kg bolus dose over 5 min, followed by a continuous infusion of 10 mg/kg/h over 20 min. Blood tests and blood pressure measurements were performed at 0, 5, 25 and 55 min after NM administration. Results: Activated thromboplastin times at 0, 25 and 55 min were 13.0 +/- 0.7 s, 106.7 +/- 13.3 s and 28.2 +/- 2.9 s, respectively, with a significant difference between 0 and 25 min (p <0.01) only. No significant differences were observed in prothrom bin time, antithrombin, fibrinogen and fibrin degradation product concentrations between timepoints. Activated clotting times (ACTs) at 0, 5, 25 and 55 min were 119.5 +/- 9.6 s, 826.7 +/- 78.6 s, 924.8 +/- 42.4 s and 165.2 +/- 13.5 s, respectively. Significant differences were observed between 0 and 5 min (p < 0.05) and between 0 and 25 min (p < 0.05). Blood pressure changes occurred in four dogs (66.7%). No other serious adverse effects were observed. Conclusions: ACT results indicated that NM use in anaesthetised healthy dogs was sufficient to obtain procedural anticoagulation with minimal adverse effects. However, these preliminary data require validation in further studies on cardiopulmonary bypass surgery.
- Open Access
- 23 June 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 918457
Reference Values of M-mode Echocardiographic Parameter in Adult Toy Breed Dogs
Introduction: Myxomatous mitral valve disease (MMVD) is one of the most common heart diseases in dogs, and there is a dearth of reports that have investigated reference values for left ventricular end-diastolic internal diameter corrected for body weight (LVIDDN) exclusively in toy breeds. Animals: Eighty-six client-owned healthy dogs weighing Materials and Methods: Experienced echocardiographers performed transthoracic echocardiography, with reference ranges established using healthy dogs. Measurements of body weight (BW), heart rate, and several echocardiographic variables were obtained. The association between BW and echocardiographic parameters was assessed by linear regression analyses. M-mode measurements were obtained and normalized using equations developed from the regression analyses. Results: The LVIDDN value for 95% of dogs weighing Conclusions: We propose a reference LVIDDN value of ≥1.6 for the diagnosis of stage B2 MMVD in toy breed dogs. The results of our study will guide clinicians in deciding when to start treatment for MMVD in small breed dogs.
- 23 June 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 918457
Open AccessReference Values of M-mode Echocardiographic Parameter in Adult Toy Breed Dogs
Introduction: Myxomatous mitral valve disease (MMVD) is one of the most common heart diseases in dogs, and there is a dearth of reports that have investigated reference values for left ventricular end-diastolic internal diameter corrected for body weight (LVIDDN) exclusively in toy breeds. Animals: Eighty-six client-owned healthy dogs weighing Materials and Methods: Experienced echocardiographers performed transthoracic echocardiography, with reference ranges established using healthy dogs. Measurements of body weight (BW), heart rate, and several echocardiographic variables were obtained. The association between BW and echocardiographic parameters was assessed by linear regression analyses. M-mode measurements were obtained and normalized using equations developed from the regression analyses. Results: The LVIDDN value for 95% of dogs weighing Conclusions: We propose a reference LVIDDN value of ≥1.6 for the diagnosis of stage B2 MMVD in toy breed dogs. The results of our study will guide clinicians in deciding when to start treatment for MMVD in small breed dogs.
- Open Access
- 22 November 2021
- Published by Wiley in Veterinary Record Case Reports
- Vol. 10 (1) , e237
Dobutamine infusion without pericardiocentesis as a treatment for cardiac tamponade due to left atrial rupture in a dog
We describe the successful management of an obstructive shock case caused by cardiac tamponade following atrial rupture. The dog was an 11‐year‐old female chihuahua with a 1‐year history of mitral valve insufficiency. During a radiographic examination, the dog collapsed. We diagnosed a case of obstructive shock caused by cardiac tamponade following left atrial rupture, secondary to mitral valve regurgitation. After administration of atropine and dobutamine, the blood pressure stabilised. The dog regained consciousness and was discharged 96 hours after collapse. The use of dobutamine should be considered in selected obstructive shock cases and may reduce the high mortality rate associated with atrial rupture.
- 22 November 2021
- Published by Wiley in Veterinary Record Case Reports
- Vol. 10 (1) , e237
Open AccessDobutamine infusion without pericardiocentesis as a treatment for cardiac tamponade due to left atrial rupture in a dog
We describe the successful management of an obstructive shock case caused by cardiac tamponade following atrial rupture. The dog was an 11‐year‐old female chihuahua with a 1‐year history of mitral valve insufficiency. During a radiographic examination, the dog collapsed. We diagnosed a case of obstructive shock caused by cardiac tamponade following left atrial rupture, secondary to mitral valve regurgitation. After administration of atropine and dobutamine, the blood pressure stabilised. The dog regained consciousness and was discharged 96 hours after collapse. The use of dobutamine should be considered in selected obstructive shock cases and may reduce the high mortality rate associated with atrial rupture.
- Open Access
- 25 March 2013
- Published by Springer Nature in BMC Veterinary Research
- Vol. 9 (1) , 54
Comparison of vascular smooth muscle cells in canine great vessels
Background: Elucidating the histological characteristics of normal vascular smooth muscle cells (VSMCs) is important for understanding mechanisms of development, disease etiology and the remodeling and/or regeneration process of the vessel. However, knowledge regarding VSMCs is focused primarily on the artery. Although the characteristics of each great vessel are documented, few studies have examined VSMCs in parallel within each great vessel. The present study focused on comparing characteristics of canine VSMCs within the aorta (Ao), branch pulmonary artery (bPA), main pulmonary artery (mPA) and inferior vena cava (IVC), simultaneously. Results: Western blot and immunohistochemistry were used to determine VSMC protein content for alpha smooth muscle actin (ASMA), calponin, myosin heavy chain (MHC) and its isozyme SM2, and non-muscle myosin heavy chain B (SMemb). Thickness and ratio of the VSMC layer were also measured. Expression levels of ASMA, calponin and SM2 significantly differed between vessels, except between mPA and either bPA, Ao and IVC vessels. Expression levels of MHC were significantly different in all vessels, whilst expression of SMemb was significantly different in the Ao compared with either bPA and mPA vessels. All vessels were significantly different with respect to total wall and VSMC layer thickness. The ratio between VSMC layer and total wall thickness was significantly different for each vessel, except between bPA and mPA vessels. Histological analysis of the IVC revealed that the VSMC layer does not line evenly and continuously through the long axis or transverse sections. With respect to the pulmonary artery, calponin was expressed to a greater extent in the mPA compared with the bPA (P < 0.01*). In contrast, MHC and SM2 were expressed to a greater extent in the bPA compared with the mPA (P < 0.01*). Differences in VSMC distribution indicate structural differences in the proximal and distal pulmonary artery bifurcation. Conclusion: Our results show that the VSMC expression pattern in each great vessel is unique and suggestive of the developmental differences between great vessels. We believe this study provides basic data for the pathology, etiology and regenerative capability of the vessels.
- 25 March 2013
- Published by Springer Nature in BMC Veterinary Research
- Vol. 9 (1) , 54
Open AccessComparison of vascular smooth muscle cells in canine great vessels
Background: Elucidating the histological characteristics of normal vascular smooth muscle cells (VSMCs) is important for understanding mechanisms of development, disease etiology and the remodeling and/or regeneration process of the vessel. However, knowledge regarding VSMCs is focused primarily on the artery. Although the characteristics of each great vessel are documented, few studies have examined VSMCs in parallel within each great vessel. The present study focused on comparing characteristics of canine VSMCs within the aorta (Ao), branch pulmonary artery (bPA), main pulmonary artery (mPA) and inferior vena cava (IVC), simultaneously. Results: Western blot and immunohistochemistry were used to determine VSMC protein content for alpha smooth muscle actin (ASMA), calponin, myosin heavy chain (MHC) and its isozyme SM2, and non-muscle myosin heavy chain B (SMemb). Thickness and ratio of the VSMC layer were also measured. Expression levels of ASMA, calponin and SM2 significantly differed between vessels, except between mPA and either bPA, Ao and IVC vessels. Expression levels of MHC were significantly different in all vessels, whilst expression of SMemb was significantly different in the Ao compared with either bPA and mPA vessels. All vessels were significantly different with respect to total wall and VSMC layer thickness. The ratio between VSMC layer and total wall thickness was significantly different for each vessel, except between bPA and mPA vessels. Histological analysis of the IVC revealed that the VSMC layer does not line evenly and continuously through the long axis or transverse sections. With respect to the pulmonary artery, calponin was expressed to a greater extent in the mPA compared with the bPA (P < 0.01*). In contrast, MHC and SM2 were expressed to a greater extent in the bPA compared with the mPA (P < 0.01*). Differences in VSMC distribution indicate structural differences in the proximal and distal pulmonary artery bifurcation. Conclusion: Our results show that the VSMC expression pattern in each great vessel is unique and suggestive of the developmental differences between great vessels. We believe this study provides basic data for the pathology, etiology and regenerative capability of the vessels.